Trending Articles

  1. Piramal Pharma reports Q2 and H1 FY26 results amid CDMO challenges CDMO growth impacted by inventory destocking while consumer healthcare posts mid-teen growth
  2. Sofinnova Partners closes €650m ($750m) Capital XI fund to boost early-stage biotech investment across Europe and the US Sofinnova Partners has closed its flagship Capital XI fund at €650m, surpassing its target. The Paris-based firm will use the fund to advance early-stage biotech and medtech...
  3. Johnson & Johnson to acquire Halda Therapeutics for $3.05bn, expanding US oncology drug pipeline Johnson & Johnson has agreed to acquire Connecticut-based Halda Therapeutics for $3.05bn. The deal strengthens its oncology portfolio, including Halda’s first-in-class RIPTAC...
  4. Pfizer completes $10bn acquisition of Metsera to kickstart its GLP-1 goals The acquisition brings promising clinical-stage obesity candidates into Pfizer's portfolio, giving the pharma company a leg up in one of the most dynamic and high-growth...
  5. Pfizer clinches $10bn deal to acquire weight-loss biotech Metsera after bidding war with Novo Nordisk Metsera says that it has opted for Pfizer's revised deal after antitrust concerns surrounding rival Novo's bid for the biotech

You may also like

Finance HitGen will use its DNA-encoded library platform to identify new drug leads for TB, malaria and non-hormonal contraception. The new Gates Foundation agreement expands on...

HitGen secures Gates Foundation funding to advance drug discovery for tuberculosis, malaria and contraception

Read more
Finance Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country

Almac announces multi-million-pound investment in Singapore

Read more
Finance hVIVO’s German subsidiary CRS has signed more than £5 million in early-phase clinical trial contracts across cardiometabolic, dermatology, infectious disease, renal and...

hVIVO’s CRS secures more than £5m in early-phase clinical trial contracts to strengthen 2026 pipeline

Read more
Finance Sofinnova Partners has closed its flagship Capital XI fund at €650m, surpassing its target. The Paris-based firm will use the fund to advance early-stage biotech and medtech...

Sofinnova Partners closes €650m ($750m) Capital XI fund to boost early-stage biotech investment across Europe and the US

Read more
Finance Johnson & Johnson has agreed to acquire Connecticut-based Halda Therapeutics for $3.05bn. The deal strengthens its oncology portfolio, including Halda’s first-in-class RIPTAC...

Johnson & Johnson to acquire Halda Therapeutics for $3.05bn, expanding US oncology drug pipeline

Read more
Finance The acquisition brings promising clinical-stage obesity candidates into Pfizer's portfolio, giving the pharma company a leg up in one of the most dynamic and high-growth...

Pfizer completes $10bn acquisition of Metsera to kickstart its GLP-1 goals

Read more
Finance CARBOGEN AMCIS today announced the successful refinancing and enhancement of its credit facilities through the banking syndication led by UBS Switzerland AG

CARBOGEN AMCIS secures refinancing to support growth and investment

Read more
Manufacturing CDMO growth impacted by inventory destocking while consumer healthcare posts mid-teen growth

Piramal Pharma reports Q2 and H1 FY26 results amid CDMO challenges

Read more
Finance Metsera says that it has opted for Pfizer's revised deal after antitrust concerns surrounding rival Novo's bid for the biotech

Pfizer clinches $10bn deal to acquire weight-loss biotech Metsera after bidding war with Novo Nordisk

Read more
Finance The Delaware Chancery Judge rejected Pfizer's request for a temporary restraining order, arguing that the company's objections to Novo's proposed deal weren't a legitimate...

Pfizer denied restraining order on rival Novo Nordisk in GLP-1 bidding war

Read more
Finance Custom Pharmaceuticals Ltd has launched Centrix Pharma Solutions, a new company dedicated to accelerating drug product development through collaboration with biotech firms and...

Custom Pharmaceuticals launches new company to foster breakthrough drug development and strategic partnerships

Read more
Finance Metsera has said Novo Nordisk’s revised offer is a “superior proposal” to Pfizer’s, escalating a high-stakes legal and acquisition battle and where Pfizer has filed a...

Metsera declares $10bn Novo deal "superior" after Pfizer files second lawsuit in GLP-1 row

Read more
Finance The transaction brings together two iconic American companies to create a combined portfolio of complementary products, including 10 billion-dollar brands, that touch nearly...

Kimberley-Clark to acquire Tylenol maker Kenvue in landmark $40bn deal

Read more
Finance Pfizer has filed a lawsuit against Metsera, its Board of Directors and Novo Nordisk, alleging breach of contract, fiduciary duty and interference following Metsera’s decision...

Pfizer sues Metsera and Novo Nordisk over alleged breach of merger agreement

Read more
Finance Acquisition to include Red One solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for...

Lonza to expand bioscience testing offering with the acquisition of Redberry

Read more
Finance The flow chemistry centre of excellence includes more than 100 R&D and manufacturing scientists

Shilpa Medicare opens flow chemistry manufacturing centre

Read more